Clinical Trials Browser

Phase 1/2 × Terminated × Clofarabine × Clear all

Leukemia, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01629511 2020-02-24

Allogeneic Stem Cell Transplant for CLL

Phase 1/2 Terminated

15 enrolled 12 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

NCT00691652 2019-11-27

Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma

Phase 1/2 Terminated

2 enrolled 4 charts

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01160354 2019-08-28

Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)

Phase 1/2 Terminated

22 enrolled 9 charts

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT00626626 2018-04-25

Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation

Phase 1/2 Terminated

8 enrolled 9 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Lymphoma, Mantle-Cell

NCT00708721 2017-06-01

Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Phase 1/2 Terminated

11 enrolled 11 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Neoplasms, Leukemia, Myelomonocytic, Chronic

Clinical Trials

Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic Leukemia

Allogeneic Stem Cell Transplant for CLL

Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma

Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)

Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation

Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia